Opinion

Ares and BDT Capital land major hires and Grubhub mulls its options.

CCS Medical is seeking a buyer and fear of the coronavirus hits the private equity meeting circuit.

Thoma Bravo kicks off the year with a new fund. Also, check out Venture Capital Journal's new feature highlighting 40 rising VC stars under 40.

Dyal Capital is closing in on a $1 billion loan and Lightyear Capital backs Health Plan One.

Charlesbank puts Ensono on the block and Pamlico raises $1.4 billion for its fifth fund.

More information on Thoma Bravo's new fund; plus, a new study reveals an increase in the number of deal co-investors.

Some of the early lessons that Heller learned from his time in service now help him manage a team of investment professionals at KKR's NGT team globally as well as build meaningful relationships with founders and CEOs.

By Allen Latta, Campton Private Equity Advisors Thousands of private equity funds are being raised right now.[1]  For a fund in the market, that’s a massive amount of competition.  Limited partners (or LPs), the investors in private equity funds, are constantly meeting with general partners (GPs), the fund managers, to select the very best funds […]

Keysight Technologies is acquiring Carlyle-backed Eggplant Software and Liquidnet goes on the block.

The primary care provider for seniors surprises the market with plans to merge with a SPAC sponsored by real estate investor Barry Sternlicht.